Lemaitre Vascular (LMAT) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $82.13 --0%
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $19 million versus the consensus estimate of $18.8 million.
Lemaitre Vascular sees FY2015 revenue of $78.0 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- Arcos Dorados (ARCO) Tops Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
